Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.

FDA 483 - Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA inspected Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. in Changzhou, China, an API manufacturer. The inspection revealed significant deficiencies in control record management, specifically regarding logbook reconciliation and the lack of hard-bounded, numbered pages. Additionally, the firm's quality assurance unit failed to conduct comprehensive reviews of electronic data and audit trails for analytical results.

Company: Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Truong Xuan Nguyen (issuing_officer)

Open in Dashboard

ID · 88731eb4-5ab6-4b2a-b83c-bc408946c100